+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pranlukast"

From
Asthma Therapeutics Market Report 2025 - Product Thumbnail Image

Asthma Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Pranlukast is a leukotriene receptor antagonist (LTRA) used to treat asthma. It is a prescription drug that works by blocking the action of leukotrienes, which are substances in the body that can cause asthma symptoms. Pranlukast is used to prevent asthma attacks and to reduce the severity of asthma symptoms. It is usually taken once a day, either in the morning or evening. Pranlukast is generally well tolerated, with the most common side effects being headache, nausea, and diarrhea. Pranlukast is one of several drugs used to treat asthma. Other drugs used to treat asthma include inhaled corticosteroids, long-acting beta-agonists, and combination inhalers. Pranlukast is often used in combination with other asthma medications to provide better control of asthma symptoms. In the Pranlukast market, some of the companies include AstraZeneca, Merck, and GlaxoSmithKline. Show Less Read more